Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04090775
Title A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Rampart Health, L.L.C.

prostate neuroendocrine neoplasm

prostate adenocarcinoma


Cyclophosphamide + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.